22Dec 2023
Akums launches Doxylamine + Pyridoxine extended-release tablets

Akums launches Doxylamine + Pyridoxine extended-release tablets

Akums Drugs and Pharmaceuticals Ltd has announced the launch of Doxylamine + Pyridoxine extended-release tablets, an approved therapy by the Central Drugs Standard Control Organisation (CSDCO), India, and the United States Food and Drug Administration (US FDA). The tablets contain Doxylamine, an inhibitor of histamine HI receptors with sedative and anticholinergic effects, and Pyridoxine Hydrochloride (Vitamin B6), renowned for anti-emetic properties, haemoglobin production, and neurotransmitter metabolism. This synergistic blend aims to provide an effective solution for managing pregnancy-related nausea and vomiting, promoting improved outcomes for both mothers and infants.

  • #family health

Like

Save

Share